sentence: In addition , HER3 growth factor ligands , heregulins ( a.k.a. neuregulins ) , mediate resistance to the anti-HER2 monoclonal antibody trastuzumab and the dual HER2 / EGFR tyrosine kinase inhibitor lapatinib [ 11 , 12 ] .